carbamates has been researched along with Tuberculosis, Multidrug-Resistant in 3 studies
Tuberculosis, Multidrug-Resistant: Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sangana, R | 1 |
| Gu, H | 1 |
| Chun, DY | 1 |
| Einolf, HJ | 1 |
| Baranyai, Z | 1 |
| Krátký, M | 1 |
| Vinšová, J | 1 |
| Szabó, N | 1 |
| Senoner, Z | 1 |
| Horváti, K | 1 |
| Stolaříková, J | 1 |
| Dávid, S | 1 |
| Bősze, S | 1 |
| White, EL | 1 |
| Suling, WJ | 1 |
| Ross, LJ | 1 |
| Seitz, LE | 1 |
| Reynolds, RC | 1 |
3 other studies available for carbamates and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches.
Topics: Antitubercular Agents; Area Under Curve; Carbamates; Clofazimine; Cytochrome P-450 Enzyme Inhibitors | 2018 |
Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Topics: Anti-Bacterial Agents; Carbamates; Cell Line; Dose-Response Relationship, Drug; Esters; Humans; Micr | 2015 |
2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.
Topics: Animals; Antitubercular Agents; Azepines; Bacterial Proteins; Bone Marrow Cells; Carbamates; Chloroc | 2002 |